Pharmaceuticals company Bayer says its subsidiary Monsanto will continue to sell its Roundup weed killer in SA despite a US jury last month awarding nearly $80m (R1.1bn) to a man who claimed it had given him cancer. According to court documents, Edwin Hardeman, 70, used Roundup for 30 years. Though no direct link between Hardeman's cancer and Roundup has been confirmed, the jury voted in his favour on the basis that there were insufficient warnings about the risk of using the product. Last year, a jury awarded Dewayne Johnson, who has non-Hodgkin's lymphoma, $78m in damages for his exposure to Roundup. 'Not carcinogenic' Magda du Toit, corporate engagement manager for Bayer SA, said: "We are disappointed with the jury's decision, but this verdict does not change the weight of over four decades of extensive science and the conclusions of regulators worldwide that support the safety of our glyphosate-based herbicides and that they are not carcinogenic. "The verdict . has no impact on ...

BL Premium

This article is reserved for our subscribers.

A subscription helps you enjoy the best of our business content every day along with benefits such as exclusive Financial Times articles, ProfileData financial data, and digital access to the Sunday Times and Times Select.

Already subscribed? Simply sign in below.

Questions or problems? Email or call 0860 52 52 00. Got a subscription voucher? Redeem it now